{
    "nctId": "NCT03590704",
    "briefTitle": "Safety of the Use of Compressive Taping in Seroma",
    "officialTitle": "Evaluation of Tolerance and Cutaneous Reaction to the Use of Compressive Taping in the Seroma After Surgical Treatment of Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Seroma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 35,
    "primaryOutcomeMeasure": "Assess dermal changes of using the compressive bandage as a treatment for seroma",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women who developed seroma after surgical treatment for breast cancer, detected by nursing team.\n\nExclusion Criteria:\n\n* bilateral breast cancer\n* neoadjuvant radiotherapy\n* wound infection\n* reporting of autoimmune diseases (dermatomyositis, hidradenitis suppurativa, nephropathy, lupus erythematosus, morphea, psoriasis, pemphigus vulgaris, scleroderma)\n* patients with difficulties of understanding.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}